Company Profile
Italian Company part of the ITALFARMACO Group. IP analysis expertise / forceful patent challenge skills. Diversified technology and skills in sophisticated molecules development & production. Qualified QC/QA department for analytical and regulatory development. Development and registration of dossiers for injectable and solid finished dosage forms.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
1H-Benzimidazole-2-butanoicacid, 5-[bis(2-chloroethyl)amino]-1-methyl-, hydrochloride (1:?) |
4-[5-[Bis(2-chloroethyl)amino]-1-methyl-benzimidazol-2-yl]butyric acid hydrochloride;Bendamustine |
97832-05-8 | Inquiry | |
5-Aza-2'-deoxycytidine |
1,3,5-Triazin-2(1H)-one,4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-;s-Triazin-2(1H)-one,4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-;4-Amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one;5-Aza-2′-deoxycytidine;5-Azadeoxycytidine;2-Desoxy-5-azacytidine;2′-Deoxy-5-azacytidine;Decitabine;NSC 127716;DAC;Dacogen;β-Decitabine;5-Aza-2-deoxycytidine;4-Amino-1-(2-deoxy-β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one;A 2232;NSC127716;105597-46-4;123795-43-7 |
2353-33-5 | Inquiry | |
5-Azacytidine |
1,3,5-Triazin-2(1H)-one,4-amino-1-β-D-ribofuranosyl-;s-Triazin-2(1H)-one,4-amino-1-β-D-ribofuranosyl-;4-Amino-1-β-D-ribofuranosyl-1,3,5-triazin-2(1H)-one;Antibiotic U 18496;5-Azacytidine;U 18496;NSC 102816;Azacitidine;Azacytidine;NSC 103-627;5-AZCR;Mylosar;5-AC;WR 183027;5-AzaC;5-AZC;Ladakamycin;Ledakamycin;Vidaza;CC 486;5-Azacitidine;52934-49-3;292869-98-8 |
320-67-2 | Inquiry | |
Bivalirudin |
128270-60-0 | Inquiry | ||
Bortezomib |
Boronic acid,B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;Boronic acid,[3-methyl-1-[[1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-,[S-(R*,S*)]-;Boronic acid,[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-;B-[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid;PS 341;PS 341 (pharmaceutical);MG 341;LDP 341;Bortezomib;MLN 341;Velcade;NSC 681239;DPBA;Radiciol;PS 314;Brotezamide;197730-97-5 |
179324-69-7 | Inquiry | |
Eptifibatide |
MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;INTEGRELIN;Eptifibatide;N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;Intrifiban;N6-(AMinoiMinoMethyl)-N2-(3-Mercapto-1-oxopropyl)-L-lysylglycyl-L-.alpha.-aspartyl-L-tryptophyl-L-prolyl-L-cysteinaMide Cyclic (16)-Disulfide;3-Mercaptopropionyl-HoMoarg-Gly-Asp-Trp-Pro-Cys-NH2 |
188627-80-7 | Inquiry | |
Octreotide |
SANDOSTATIN;SMS-201-995;[r-(r*,r*)]-d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-[2-hydroxy-1-(hydroxy-methyl)propyl]-cysteinamide cyclic(2->7)-disulfide;OCTREOTIDE;OCTREOTIDE (SMS 201-995), ACETATE;cyclic(2-7)-disulfide,(r-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl);d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-cysteinamid;r*))-(racetate(salt) |
79517-01-4 | Inquiry | |
Zoledronic acid |
Phosphonic acid,P,P′-[1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-;Phosphonic acid,[1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-;P,P′-[1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis[phosphonic acid];(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid;Zoledronic acid;CGP 42446;Zoledronate;Zometa;1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene-1,1-bisphosphonic acid;ZOL 446;2-(Imidazol-1-yl)-1-hydroxy-1,1′-ethylidenediphosphonic acid;BPH 91;Reclast;Orazol;Aclasta;[1-Hydroxy-2-(1H-imidazol-1-yl)-1-phosphonoethyl]phosphonic acid;(1-Hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid;1-Hydroxy-2-(1-imidazolyl)ethane-1,1-diphosphonic acid |
118072-93-8 | Inquiry |
CONTACT INFORMATION
Sign In for Details